Clinical Trials
9 trialsNCT03063632 2023-10-25
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00006113 2014-05-22
Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
University of Southern California
Phase 2 Terminated
NCT00024271 2014-01-06
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00002475 2013-07-10
Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00059878 2013-06-19
Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
National Cancer Institute (NCI)
Phase 2 Completed
NCT00501644 2012-08-07
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00786643 2012-03-01
GFL
Accelerated Community Oncology Research Network
Phase 2 Completed
NCT00616720 2011-05-16
Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
Mayo Clinic
Phase 2 Completed
NCT00002505 2011-05-12
Tumor Cell Vaccine in Treating Patients With Advanced Cancer
Hoag Memorial Hospital Presbyterian
Phase 2 Completed